Kamada KMDA
NASDAQ KMDA
$7.69 +0.46 (+6.36%)
At close: Nov 9, 2026 · 4:00 PM EST

Kamada (KMDA) FCF Margin (2012 - 2026)

Updated

Kamada (KMDA) reported FCF Margin of 36.73% for the quarter ended Jun 30, 2026, up 14.31 percentage points from 22.42% a year earlier and up 35.23 percentage points from the prior quarter.

Analysis

Kamada (KMDA) FCF Margin (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kamada's FCF Margin came in at 23.56%, down 5.14 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 19.58%, down 16.66 percentage points from the prior year.

  • FCF Margin has a five-year change of +1.12 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, FCF Margin came in at 36.24% in the year ended Dec 31, 2024 (+29.11 pp), 7.13% in the year ended Dec 31, 2023 (-17.89 pp), 25.03% in the year ended Dec 31, 2022 (+29.94 pp) and -4.91% in the year ended Dec 31, 2021 (-23.37 pp).
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly FCF Margin since the quarter ended Sep 30, 2024.
  • Year over year, FCF Margin gained in three of the last eight quarters, with an average year-over-year change of +1.53 percentage points.
  • The high point for year-over-year FCF Margin in five years was the quarter ended Jun 30, 2022 (a gain of 57.06 percentage points); the low point was the quarter ended Dec 31, 2021 (a drop of 60.55 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 1.51% (quarter ended Mar 31, 2026), 23.15% (quarter ended Dec 31, 2025) and 29.79% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 25.03%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 41.97%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 30.51%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 52.85%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 35.25%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 57.81%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 28.96%
10 Kamada 441.57 Mn 150.63 Mn 22.47 Mn 29.06%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.06%
Mar 31, 2026 -2.79%
Dec 31, 2025 10.72%
Sep 30, 2025 14.52%
Jun 30, 2025 13.42%
Mar 31, 2025 -4.50%
Dec 31, 2024 19.16%
Sep 30, 2024 48.13%
Jun 30, 2024 25.79%
Mar 31, 2024 -4.40%
Dec 31, 2023 6.69%
Sep 30, 2023 -2.13%
Jun 30, 2023 2.10%
Mar 31, 2023 -0.01%
Dec 31, 2022 54.54%
Sep 30, 2022 0.01%
Jun 30, 2022 43.28%
Mar 31, 2022 17.63%
Dec 31, 2021 -18.15%
Sep 30, 2021 -18.21%
API Access

Kamada FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=KMDA&period=max&api_key=YOUR_API_KEY